Kassim Javaid
Associate Professor
- University Lecturer in Metabolic Bone Disease
Kassim Javaid studied medicine at Charing Cross and Westminster Medical School, and did his house jobs in London. He then finished a three year SHO rotation in medicine at Southampton General Hospital followed by 8 months as a registrar before starting at the MRC Environmental Epidemiology Unit in October 2000.
His research areas are in epidemiology and adult metabolic bone disease focusing vitamin D, osteoporosis, secondary fracture prevention and rare bone diseases.
Key publications
-
Determinants of the Maternal 25-Hydroxyvitamin D Response to Vitamin D Supplementation During Pregnancy.
Journal article
Moon RJ. et al, (2016), J clin endocrinol metab, 101, 5012 - 5020
Recent publications
-
Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium
Journal article
Javaid MK. et al, (2019), Orphanet journal of rare diseases, 14
-
Unplanned admissions for patients with myeloma in the UK: Low frequency but high costs.
Journal article
Kolovos S. et al, (2019), J bone oncol, 17
-
Testing and management for monoclonal gammopathy of uncertain significance and myeloma patients presenting with osteoporosis and fragility fractures.
Journal article
Nador G. et al, (2019), Rheumatology (oxford), 58, 1142 - 1153
-
Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period.
Journal article
Portale AA. et al, (2019), Calcif tissue int
-
ORAL BISPHOSPHONATE USE AND ALL-CAUSE MORTALITY IN PATIENTS WITH ADVANCED (STAGE IIIB plus ) CHRONIC KIDNEY DISEASE: A POPULATION-BASED COHORT STUDY
Conference paper
Alarkawi D. et al, (2019), Osteoporosis international, 30, S106 - S106